As part of the agreement, Carlyle Group (NASDAQ:CG) and SK Capital will also provide bluebird (NASDAQ:BLUE) with primary capital to expand the commercial reach of its gene therapies targeted at ...
Carlyle (NASDAQ: CG) and SK Capital Partners will acquire bluebird bio (NASDAQ: BLUE), according to a news release. bluebird, founded in 2010 and based in Somerville, Massachusetts, is a gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback